As part of the BRIDGE initiative, FasterCures seeks to highlight novel partnerships involving deprioritized drugs that can serve as models for future transactions. This article discusses an innovative case study from the UK’s AMR Centre...

Washington, D.C. – September 1, 2020 – The Milken Institute Center for Strategic Philanthropy (CSP) has released a series of reports focused on how philanthropists can lead strategic initiatives to rebuild better health, education...

The Milken Institute has been chosen as the Research Organization of the Year by Los Angeles Business Journal. The award, which was presented at the Business Journal's 2020 Health Care Panel & Awards virtual event, was accepted on behalf of...

This Innovative Medicines Initiative (IMI) report demonstrates how the first projects launched by IMI made concrete improvements to pharmaceutical research and development (R&D); leveraging funding; creating new knowledge and tools; and...

Situation With more than 6 million cases worldwide, Parkinson’s disease (PD) is the most common and fastest-growing neurodegenerative condition. Currently, there are no treatments that can slow or stop the relentless progression of the...

COVID-related impacts on biomedical research logistics, funding, and human talent have put the entire biomedical research ecosystem at risk. Without immediate attention and support for this medical research ecosystem, progress toward better...

Rare disease represents one of the most significant issues facing the medical community and health care providers worldwide, yet the majority of these disorders never emerge from their obscurity, drawing little attention from the medical...

The NF Preclinical Initiative (NFPI) represents one of the Children’s Tumor Foundation’s groundbreaking models of scientific collaboration. The NFPI is aimed at accelerating proof of concept testing of potential effective repurposed drugs...

IBD Plexus is a research and information exchange platform whose goal is to accelerate research and transform the care of patients with inflammatory bowel disease (IBD). IBD Plexus will unite clinicians, patients, academia, and industry to...